Davis Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Davis Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40	Buy	+2	New	+$40	﹤0.01%	1242

Other funds holding AMPH

LAM Group Lake Oswego, Oregon $201M AUM 22.35% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SIM

SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Davis Capital Management's AMPH Position: Q2 2026 in Review

Davis Capital Management opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 2 shares worth $40. The stake represents ﹤0.01% of the portfolio and ranks #1242 among its holdings.

39 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

Davis Capital Management held 2 shares of Amphastar Pharmaceuticals worth $40 as of Q2 2026.
Amphastar Pharmaceuticals was a new Davis Capital Management position in Q2 2026.
Amphastar Pharmaceuticals made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1242 holding.
39 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.